These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9061808)

  • 1. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging?
    DeLisi LE
    Schizophr Res; 1997 Feb; 23(2):119-29. PubMed ID: 9061808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
    Ho BC; Andreasen NC; Nopoulos P; Arndt S; Magnotta V; Flaum M
    Arch Gen Psychiatry; 2003 Jun; 60(6):585-94. PubMed ID: 12796222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses.
    Gogtay N; Sporn A; Clasen LS; Nugent TF; Greenstein D; Nicolson R; Giedd JN; Lenane M; Gochman P; Evans A; Rapoport JL
    Arch Gen Psychiatry; 2004 Jan; 61(1):17-22. PubMed ID: 14706940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antipsychotic medication in the elderly.
    Maletta GJ
    Annu Rev Gerontol Geriatr; 1984; 4():175-220. PubMed ID: 6152711
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.
    Lieberman JA; Malaspina D; Jarskog LF
    CNS Spectr; 2006 Apr; 11(4):suppl 1-13; quiz suppl 14-5. PubMed ID: 16641837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101.
    Waddington JL; Scully PJ; Youssef HA
    Schizophr Res; 1997 Feb; 23(2):107-18. PubMed ID: 9061807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia.
    Gogtay N; Greenstein D; Lenane M; Clasen L; Sharp W; Gochman P; Butler P; Evans A; Rapoport J
    Arch Gen Psychiatry; 2007 Jul; 64(7):772-80. PubMed ID: 17606811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Schizophrenia: neurodevelopmental disorder or degenerative brain process?].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S57-62. PubMed ID: 18461546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related cortical thinning in schizophrenia.
    Kubota M; Miyata J; Yoshida H; Hirao K; Fujiwara H; Kawada R; Fujimoto S; Tanaka Y; Sasamoto A; Sawamoto N; Fukuyama H; Murai T
    Schizophr Res; 2011 Jan; 125(1):21-9. PubMed ID: 21036016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult neurogenesis and schizophrenia: a window on abnormal early brain development?
    Toro CT; Deakin JF
    Schizophr Res; 2007 Feb; 90(1-3):1-14. PubMed ID: 17123784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental schizophrenia: the rediscovery of dementia praecox.
    Murray RM
    Br J Psychiatry Suppl; 1994 Nov; (25):6-12. PubMed ID: 7865195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiopathogenesis and treatment of psychosis.
    Crow TJ; Harrington CA
    Annu Rev Med; 1994; 45():219-34. PubMed ID: 7911014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia in childhood and adolescence.
    Mala E
    Neuro Endocrinol Lett; 2008 Dec; 29(6):831-6. PubMed ID: 19112396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative clinico-epidemiologic characteristics of affective psychoses and periodic schizophrenia].
    Panicheva EV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(4):550-8. PubMed ID: 1210967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia.
    Hoff AL; Sakuma M; Razi K; Heydebrand G; Csernansky JG; DeLisi LE
    Am J Psychiatry; 2000 Nov; 157(11):1824-8. PubMed ID: 11058480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental insanity or dementia praecox: was the wrong concept adopted?
    O'Connell P; Woodruff PW; Wright I; Jones P; Murray RM
    Schizophr Res; 1997 Feb; 23(2):97-106. PubMed ID: 9061806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive structural brain changes in schizophrenia.
    Puri BK
    Expert Rev Neurother; 2010 Jan; 10(1):33-42. PubMed ID: 20021319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.
    Mahadik SP; Pillai A; Joshi S; Foster A
    Int Rev Psychiatry; 2006 Apr; 18(2):119-31. PubMed ID: 16777666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia: new pathological insights and therapies.
    Jarskog LF; Miyamoto S; Lieberman JA
    Annu Rev Med; 2007; 58():49-61. PubMed ID: 16903799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.